Our results are consistent with the results of Xu et al, which found that miR-145 is under-expressed in bladder cancer cell lines, and that over-expression of miR-145 inhibits cell proliferation by targeting FSCN1 [13]. This evidence concerns the gene FSCN1 and urinary bladder cancer.